Mustang Bio, Inc. (MBIO)
MBIO Stock Price Chart
Explore Mustang Bio, Inc. interactive price chart. Choose custom timeframes to analyze MBIO price movements and trends.
MBIO Company Profile
Discover essential business fundamentals and corporate details for Mustang Bio, Inc. (MBIO) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
22 Aug 2017
Employees
4.00
Website
https://www.mustangbio.comCEO
Manuel Litchman
Description
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating cell therapies into cures for difficult-to-treat cancers and autoimmune diseases in the United States. The company develops MB-106, a CD20-targeted chimeric antigen receptor (CAR) T cell therapy which is in Phase I clinical trail for non-hodgkin lymphoma, chronic lymphocytic leukemia, and autoimmune diseases; MB-109, a combination MB-101 and MB-108 as a potential treatment for IL13Ra2+ relapsed or refractory glioblastoma and high-grade astrocytoma; MB-101, an IL13Ra2 CAR T cell program completd Phase I for glioblastoma; and MB-108 which is in Phase I for the treatment of herpes simplex virus-1 oncolytic virus C134. It has a license agreement with city of hope national medical center and nationwide children’s hospital. Mustang Bio, Inc. was incorporated in 2015 and is headquartered in Waltham, Massachusetts.
MBIO Financial Timeline
Browse a chronological timeline of Mustang Bio, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 18 Aug 2026
EPS estimate is -$145.50.
Earnings released on 5 May 2026
EPS came in at -$0.14 surpassing the estimated -$140.00 by +99.90%.
Earnings released on 19 Mar 2026
EPS came in at -$0.08 surpassing the estimated -$5.50 by +98.55%.
Earnings released on 7 Nov 2025
EPS came in at -$0.07 .
Earnings released on 8 Aug 2025
EPS came in at -$0.19 .
Earnings released on 14 May 2025
EPS came in at -$0.05 .
Earnings released on 24 Mar 2025
EPS came in at -$37.95 falling short of the estimated -$5.50 by -590.00%.
Stock split effective on 16 Jan 2025
Shares were split 1 : 50 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 8 Nov 2024
EPS came in at -$2.00 surpassing the estimated -$6.50 by +69.23%.
Earnings released on 13 Aug 2024
EPS came in at -$12.00 falling short of the estimated -$7.00 by -71.43%.
Earnings released on 15 May 2024
EPS came in at -$23.00 falling short of the estimated -$0.87 by -2.54k%.
Earnings released on 11 Mar 2024
EPS came in at -$35.50 surpassing the estimated -$84.00 by +57.74%, while revenue for the quarter reached $2.88m .
Earnings released on 14 Nov 2023
EPS came in at -$61.50 surpassing the estimated -$94.00 by +34.57%.
Earnings released on 14 Aug 2023
EPS came in at -$100.00 surpassing the estimated -$103.50 by +3.38%.
Earnings released on 12 May 2023
EPS came in at -$103.00 surpassing the estimated -$142.50 by +27.72%.
Stock split effective on 4 Apr 2023
Shares were split 1 : 15 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 29 Mar 2023
EPS came in at -$134.93 surpassing the estimated -$142.43 by +5.27%.
Earnings released on 14 Nov 2022
EPS came in at -$134.93 surpassing the estimated -$149.93 by +10.00%.
Earnings released on 11 Aug 2022
EPS came in at -$142.43 surpassing the estimated -$157.42 by +9.52%.
Earnings released on 12 May 2022
EPS came in at -$149.93 falling short of the estimated -$134.93 by -11.12%.
Earnings released on 23 Mar 2022
EPS came in at -$164.92 falling short of the estimated -$157.42 by -4.76%.
Earnings released on 12 Nov 2021
EPS came in at -$142.43 falling short of the estimated -$134.93 by -5.56%.
Earnings released on 16 Aug 2021
EPS came in at -$119.94 surpassing the estimated -$149.93 by +20.00%.
MBIO Stock Performance
Access detailed MBIO performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
